Anxiety disorders in patients with idiopathic priapism: Risk factor and pathophysiologic link?

Journal of Sexual Medicine

Volumn 6, Issue 6, 2009, Pages 1712-1718

  Burnett, Arthur L ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

Attention deficit hyperactivity disorder; Erection; Ischemic; Neuropsychiatric; Penis

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; AMYL NITRITE; BICALUTAMIDE; KETOCONAZOLE; PHOSPHODIESTERASE V INHIBITOR; PSEUDOEPHEDRINE; TERBUTALINE;

ADULT; ANXIETY DISORDER; ARTICLE; ATTENTION DEFICIT DISORDER; CLINICAL ARTICLE; CLINICAL PRACTICE; DISEASE ASSOCIATION; DISEASE DURATION; DOCUMENTATION; HORMONE SUBSTITUTION; HUMAN; LAVAGE; MALE; OBSESSIVE COMPULSIVE DISORDER; PATHOPHYSIOLOGY; PHYSICAL EXAMINATION; PRIAPISM; PRIORITY JOURNAL; QUESTIONNAIRE; RISK FACTOR; TREATMENT DURATION;

EID: 66749122402     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2009.01246.x     Document Type: Article

References (32)

1. Montague DK, Jarow J, Broderick GA, Dmochowski RR, Heaton JP, Lue TF, Nehra A, Sharlip ID ; Members of the Erectile Dysfunction Guideline Update Panel; American Urological Association. American Urological Association Guideline on the management of priapism. J Urol 2003;170:1318-24.
2. Burnett AL, Bivalacqua TJ, Priapism: Current principles and practice. Urol Clin North Am 2007;34:631-42.
3. Hinman F Jr. Priapism: Reasons for failure of therapy. J Urol 1960;83:420-8.
4. Burnett AL. Pathophysiology of priapism: Dysregulatory erection physiology thesis. J Urol 2003;170:26-34.
5. Bivalacqua TJ, Burnett AL. Priapism: New concepts in the pathophysiology and new treatment strategies. Curr Urol Rep 2006;7:497-502.
6. Champion HC, Bivalacqua TJ, Takimoto E, Kass DA, Burnett AL. Phosphodiesterase-5A dysregulation in penile erectile tissue is a mechanism of priapism. Proc Natl Acad Sci U S A 2005;102:1661-6.
7. Mi T, Abbasi S, Zhang H, Uray K, Chunn JL, Xia LW, Molina JG, Weisbrodt NW, Kellems RE, Blackburn MR, Xia Y. Excess adenosine in murine penile erectile tissues contributes to priapism via A2B adenosine receptor signaling. J Clin Invest 2008;118:1491-501.
8. Burnett AL, Bivalacqua TJ, Champion HC, Musicki B. Long-term oral phosphodiesterase 5 inhibitor therapy alleviates recurrent priapism. Urology 2006;67:1043-8.
9. Burnett AL, Bivalacqua TJ, Champion HC, Musicki B. Feasibility of the use of phosphodiesterase type 5 inhibitors in a pharmacologic prevention program for recurrent priapism. J Sex Med 2006;3:1077-84.
10. Burnett AL, Bivalacqua TJ. Glucose-6-phospihate dehydrogenase deficiency: An etiology for idiopathic priapism? J Sex Med 2008;5:237-40.
11. Hinman F. Priapism: Report of cases and clinical study of the literature with reference to its pathogenesis and surgical treatment. Ann Surg 1914;60:689-716.
12. Winter CC, McDowell G. Experience with 105 patients with priapism: Update review of all aspects. J Urol 1988;140:980-3.
13. Bertram RA, Webster GD, Carson CC. Priapism: Etiology, treatment, and results in series of 35 presentations. Urology 1985;3:229-32.
14. Rosen RC, Cappelleri JC, Smith MD, Lipsky J, Peña BM. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res 1999;11:319-26.
15. Pryor J, Akkus E, Alter G, Jordan G, Lebret T, Levine L, Mulhall J, Perovic S, Ralph D, Stackl W. Priapism. J Sex Med 2004;1:116-20.
16. Levine LA, Guss SP. Gonadotropin-releasing hormone analogues in the treatment of sickle cell anemia-associated priapism. J Urol 1993;150:475-7.
17. Costabile RA. Successful treatment of stutter priapism with an antiandrogen. Tech Urol 1998;4:167-8.
18. Munarriz R, Wen CC, McAuley I, Goldstein I, Traish A, Kim N. Management of ischemic priapism with high-dose intracavernosal phenylephrine: From bench to bedside. J Sex Med 2006;3:918-22.
19. Davila HH, Parker J, Webster JC, Lockhart JL, Carrion RE. Subarachnoid hemorrhage as complication of phenylephrine injection for the treatment of ischemic priapism in a sickle cell disease patient. J Sex Med 2008;5:1025-8.
20. Faraone SV, Biederman J, Spencer T, Wilens T, Seidman LJ, Mick E, Doyle AE. Attention-deficit/hyperactivity disorder in adults: An overview. Biol Psychiatry 2000;48:9-20.
21. Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005;62:617-27.
22. Kroenke K, Spitzer RL, Williams JB, Monahan PO, Löwe B. Anxiety disorders in primary care: Prevalence, impairment, comorbidity, and detection. Ann Intern Med 2007;146:317-25.
23. Kulmala R, Lehtonen T, Nieminen P, Tammela T. Aetiology of priapism in 207 patients. Eur Urol 1995;28:241-5.
24. Biederman J, Monuteaux MC, Mick E, Wilens TE, Fontanella JA, Poetzl KM, Kirk T, Masse J, Faraone SV. Is cigarette smoking a gateway to alcohol and illicit drug use disorders? A study of youths with and without attention deficit hyperactivity disorder. Biol Psychiatry 2006;59:258-64.
25. Berger R, Billups K, Brock G, Broderick GA, Dhabuwala CB, Goldstein I, Hakim LS, Hellstrom W, Honig S, Levine LA, Lue T, Munarriz R, Montague DK, Mulcahy JJ, Nehra A, Rogers ZR, Rosen R, Seftel AD, Shabsigh R, Steers W ; AFUD Thought Leader Panel on Evaluation and Treatment of Priapism. Report of the American Foundation of Urologic Disease (AFUD) Thought Leader Panel on Evaluation and Treatment of Priapism. Int J Impot Res 2001;13(5 suppl):S39-43.
26. Saenz de Tejada I, Ware JC, Blanco R, Pittard JT, Nadig PW, Azadzoi KM, Krane RJ, Goldstein I. Pathophysiology of prolonged penile erection associated with trazodone use. J Urol 1991;145:60-4.
27. Seftel AD, Saenz de Tejada I, Szetela B, Cole J, Goldstein I. Clozapine-associated priapism: A case report. J Urol 1992;147:146-8.
28. Altman AL, Seftel AD, Brown SL, Hampel N. Cocaine-associated priapism. J Urol 1999;161:1817-8.
29. Tran QT, Wallace RA, Sim EH. Priapism, ecstasy, and marijuana: Is there a connection? Adv Urol 2008;193694:1-3.
30. Burnett AL. Priapism pathophysiology: Clues to prevention. Int J Impot Res 2003;15(5 suppl):S80-5.
31. Calvet U. Painful nocturnal erection. Sleep Med Rev 1999;3:47-57.
32. van Driel MF, Beck JJ, Elzeview HW, van der Hoeven JH, Nijman JM. The treatment of sleep-related painful erections. J Sex Med 2008;5:909-18.